5-Bromo-2'-deoxyuridine
規格
59-14-3CAS番号
200-415-9EC番号
5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dioneIUPAC名
C9H11BrN2O5化学式
307.1 g/mol分子量
5-BROMO-2'-DEOXYURIDINE; 59-14-3; Broxuridine; Bromodeoxyuridine; 5-Bromodeoxyuridine; BRDU; BUDR; 5-Bromo-2-deoxyuridine; Radibud; Broxuridina; 5-Bdu; 5-Bromouracil deoxyriboside; Bromouracil deoxyriboside; 5-Bromodesoxyuridine; Broxuridinum; 5-Bromouracil-2-deoxyriboside; Brudr; DTXSID7033105; Bromoouridine; 5-Budr; CHEBI:472552; G34N38R2N1; DTXCID5013105; NSC 38297; 5 Bromodeoxyuridine; Deoxyriboside, Bromouracil; 5 Bromo 2' deoxyuridine; RefChem:570337; 5-bromo-1-(4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione; 200-415-9; 5-BrdU; C9H11BrN2O5; Uridine, 5-bromo-2'-deoxy-; MFCD00006529; NSC-38297; 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 5-Bromo-2'-deoxyuridine (BRDU); 5-bromo-2'-deoxy uridine; CHEMBL222280; 5-Bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; NCGC00090770-05; 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione; Broxuridine [INN]; BDU; Broxuridinum [INN-Latin]; Broxuridina [INN-Spanish]; CAS-59-14-3; 1-[(4S,2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-bromo-1,3-dihydropyrim idine-2,4-dione; SMR001227189; CCRIS 818; 2'-deoxy-5-bromouridine; HSDB 7477; Broxuridine [INN:JAN]; EINECS 200-415-9; (+)-5-Bromo-2'-deoxyuridine; BRN 0030395; Bromouridine;; UNII-G34N38R2N1; 5-Bromo-2'-deoxyuridine(BRDU); 5-Bromo-dURD; 5-brom-2'-desoxyuridin; Broxuridine (JAN/INN); BROXURIDINE [MI]; Maybridge4_003385; BROXURIDINE [JAN]; BROXURIDINE [HSDB]; Epitope ID:138105; cid_6035; 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil; BROXURIDINE [MART.]; Lopac0_000212; SCHEMBL27755; BROXURIDINE [WHO-DD]; 4-24-00-01234 (Beilstein Handbook Reference); MLS001055406; MLS002153366; 5-Bromo-2'-deoxy-D-uridine; orb1224550; orb1300459; SCHEMBL6838881; SCHEMBL10581368; 5-Bromo-2'-deoxyuridine, 97%; BrdU (5-Bromo-2'-deoxyuridine); GLXC-07096; HMS1619B05; HMS3039G15; HMS3260L05; 5-BROMO-2''-DEOXY URIDINE; Tox21_111016; Tox21_200106; Tox21_500212; BDBM50207303; EBC-84151; HB0979; HG1160; SBB002964; STL530083; 5-Bromo-2'-deoxyuridine (5-Br-dU); AKOS001715166; AKOS016015753; AKOS037495737; Tox21_111016_1; CCG-204307; DB12028; LP00212; NB06315; SDCCGSBI-0050200.P002; BrdU (5-Bromo-2′-deoxyuridine); NCGC00090770-01; NCGC00090770-02; NCGC00090770-03; NCGC00090770-04; NCGC00090770-06; NCGC00090770-07; NCGC00090770-08; NCGC00090770-09; NCGC00090770-14; NCGC00175901-01; NCGC00257660-01; NCGC00260897-01; AS-11762; BP-58665; HY-15910; ST057095; SY019490; 5-Bromo-2'-deoxyuridine, >=99% (HPLC); B6856; EU-0100212; NS00034095; T6794; 5-Bromo-2'-deoxyuridine, BioUltra, >=99%; B 5002; D01763; EN300-7376709; 5-Bromo-2 inverted exclamation mark -deoxyuridine; 5-Bromo-2 inverted exclamation marka-deoxyuridine; F092742; Q419861; SR-01000075718; SR-01000075718-1; BRD-K79095980-001-09-6; 5-Bromo-2 inverted exclamation marka-deoxyuridine(BrdU); Br-dU; 5-Bromo-1-(2-deoxy-beta-D-ribofuranosyl)uracil; Carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone; (+)-5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]- pyrimidine-2,4-dione; 5-bromo-1-(2-deoxy-beta-D-erythro-pentofuranosyl)-4-hydroxypyrimidin-2(1H)-one; 3445-26-9; 5-bromo-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione別名